Fierce Pharma Asia—Samsung's deal with Pfizer; Olympus' and Dr. Reddy's M&A moves; BeiGene's growth

Fierce Pharma Asia—Samsung's deal with Pfizer; Olympus' and Dr. Reddy's M&A moves; BeiGene's growth

Pfizer teamed with Samsung Biologics. Olympus and Dr. Reddy's Laboratories struck M&A deals. BeiGene nearly doubled revenue in 2022.